Please use this identifier to cite or link to this item:
|Title:||A Preliminary Investigation of the Spence Children's Anxiety Parent Scale as a Screening Tool for Anxiety in Young People with Autism Spectrum Disorders||Authors:||Zainal, H.
Autism spectrum disorders
|Issue Date:||2014||Citation:||Zainal, H., Magiati, I., Tan, J.W.-L., Sung, M., Fung, D.S.S., Howlin, P. (2014). A Preliminary Investigation of the Spence Children's Anxiety Parent Scale as a Screening Tool for Anxiety in Young People with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders : 1-13. ScholarBank@NUS Repository. https://doi.org/10.1007/s10803-014-2075-0||Abstract:||Despite high rates of clinically elevated anxiety difficulties in children and adolescents with autism spectrum disorders (ASDs), very few studies have systematically examined the usefulness of commonly used caregiver report anxiety screening tools with this population. This study investigated the use of the Spence Children's Anxiety Scale-Parent version (SCAS-P) as a screening tool for anxiety disorders when compared to a standardized DSM-IV-TR-based clinical interview, the Kiddie-Schedule for Schizophrenia and Affective Disorders-Present and Lifetime version (K-SADS-PL). Thirty-two caregivers of youth with a clinical diagnosis of ASD (mean age 10.3 years) attending a specialist autism school participated in this study. They first completed the SCAS-P, a measure of adaptive functioning and a checklist of other emotional and behavioral difficulties. They were then interviewed with the K-SADS-PL. Internal consistency for the SCAS Total score was .88, but Cronbach's alphas were .70, except for the PPV. Evidence of convergent validity between the SCAS-P, K-SADS-PL and DBC anxiety subscale was also found. The high false positive rates notwithstanding, the preliminary data of acceptable to excellent sensitivity, specificity and NPV values tentatively suggest that the SCAS-P may be useful for screening non-help seeking young people with ASD for elevated anxiety symptoms. Further replication in larger studies is needed and ways in which the SCAS-P could be further developed and investigated for use with youth with ASD are discussed. © 2014 Springer Science+Business Media New York.||Source Title:||Journal of Autism and Developmental Disorders||URI:||http://scholarbank.nus.edu.sg/handle/10635/124615||ISSN:||01623257||DOI:||10.1007/s10803-014-2075-0|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Nov 18, 2020
WEB OF SCIENCETM
checked on Nov 18, 2020
checked on Nov 21, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.